The rapid rescue observed in 24-month-old Abcd1-/y mice in response to the AAV9-MAG-hABCD1 vector (Figure 2) [128] showing that myelopathy may still be reversible at this stage, is encouraging for AMN patients who show incipient symptoms. This evidence concerns the gene MAG and adrenomyeloneuropathy.